Stonepine Capital Management’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.36M	Sell	657,380 -138,720	-17%	-$287K	1.34%	19
2025 Q1	$1.75M	Buy	796,100 +96,100	+14%	+$211K	1.7%	19
2024 Q4	$1.07M	Buy	+700,000	New	+$1.07M	0.86%	29